Related Experiment Videos
Amiodarone-induced systemic lupus erythematosus.
1Department of Medicine, Burdwan Medical College, Burdwan, West Bengal.
Summary
Drug-induced lupus is rare, with amiodarone rarely implicated. This report details a unique case of amiodarone-induced lupus in an elderly Indian man with atrial fibrillation.
Area of Science:
- Cardiology
- Rheumatology
- Pharmacology
Background:
- Drug-induced lupus (DIL) is an uncommon condition.
- Hydralazine and procainamide are known culprits.
- Amiodarone-induced lupus has not been previously reported in Indian literature.
Observation:
- An elderly male patient with atrial fibrillation was treated with amiodarone for 1.5 years.
- The patient presented with systemic features suggestive of lupus erythematosus.
- This presentation occurred following prolonged amiodarone therapy.
Findings:
- This case represents the first reported instance of amiodarone-induced lupus in India.
- The patient's lupus-like symptoms developed after a significant duration of amiodarone use.
- The findings suggest a potential link between amiodarone and lupus induction.
Implications:
- Highlights amiodarone as a potential, albeit rare, cause of drug-induced lupus.
- Emphasizes the importance of considering medication history in lupus diagnosis.
- Suggests the need for further investigation into amiodarone's potential to induce autoimmune conditions.